Platelet serotonin-2 receptors in obsessive-compulsive disorder

Area of Science:

• Neuroscience
• Psychiatry
• Pharmacology

Background:

• Obsessive-compulsive disorder (OCD) is a debilitating mental health condition.
• The role of serotonin-2 (5-HT2) receptors in OCD pathophysiology remains unclear.
• Platelets offer a potential accessible model for studying central nervous system receptors.

Purpose of the Study:

• To investigate the density and affinity of serotonin-2 (5-HT2) receptors in platelets of individuals with OCD.
• To determine if 5-HT2 receptor characteristics correlate with OCD symptom severity.

Main Methods:

• Receptor binding techniques were employed using 125I-lysergic acid diethylamide (LSD) as a radioligand.
• Platelets were obtained from drug-free patients with OCD (n=20) and normal control subjects (n=25).
• Binding parameters, including maximum binding sites (Bmax) and dissociation constant (Kd), were quantified.

Main Results:

• No significant differences were observed in the mean Bmax of 125I-LSD binding between OCD patients and controls.
• Similarly, no significant differences in Kd values were found between the two groups.
• No significant correlations were identified between baseline Bmax or Kd and scores on the Hamilton Depression Rating Scale (HDRS), Yale-Brown Obsessive-Compulsive Scale (Y-BOCS), or NIMH-Obsessive-Compulsive Scale (GOCS).

Conclusions:

• The findings do not support the hypothesis of abnormal serotonin-2 (5-HT2) receptors in platelets of patients with obsessive-compulsive disorder.
• Platelet 5-HT2 receptor characteristics do not appear to be directly related to OCD symptom severity in this cohort.